Neutralizing antibodies to interferon-beta may persist after cessation of therapy: what impact could they have?
Polman
Chris
C
Schellekens
Huub
H
Killestein
Joep
J
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000906:Antibodies / Q000097:blood; D006801:Humans; D016899:Interferon-beta / Q000276:immunology* / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology*; D009500:Neutralization Tests
D000276:Adjuvants, Immunologic; D000906:Antibodies; D016899:Interferon-beta